NCT01553019View on ClinicalTrials.gov

Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Pancreatic Cancer
Interventions
RADIATION

Proton radiation

Proton Radiation Therapy: R(0) negative ... 50.40 cobalt gray equivalent (CGE) at 1.8 CGE per fraction ; R(1) micro-positive ...54.00 CGE at 1.8 CGE per fraction; R(2) gross positive...59.40 CGE at 1.8 CGE per fraction

DRUG

Gemcitabine

Gemcitabine 300 mg/m2 infused over 30 minutes, weekly during proton therapy.

Trial Locations (2)

32206

University of Florida Proton Therapy Institute, Jacksonville

37909

Provision Proton Therapy Center, Knoxville

All Listed Sponsors
lead

University of Florida

OTHER

NCT01553019 - Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer | Biotech Hunter | Biotech Hunter